Compare IQV & KMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IQV | KMB |
|---|---|---|
| Founded | 1982 | 1910 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.4B | 34.2B |
| IPO Year | 2013 | N/A |
| Metric | IQV | KMB |
|---|---|---|
| Price | $230.79 | $109.05 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 12 |
| Target Price | ★ $236.71 | $129.58 |
| AVG Volume (30 Days) | 1.4M | ★ 8.6M |
| Earning Date | 10-28-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 4.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 7.30 | 5.91 |
| Revenue | $15,904,000,000.00 | ★ $19,724,000,000.00 |
| Revenue This Year | $6.14 | N/A |
| Revenue Next Year | $5.28 | $3.10 |
| P/E Ratio | $31.49 | ★ $18.47 |
| Revenue Growth | 3.85 | ★ 11.62 |
| 52 Week Low | $134.65 | $99.22 |
| 52 Week High | $234.30 | $150.45 |
| Indicator | IQV | KMB |
|---|---|---|
| Relative Strength Index (RSI) | 68.05 | 51.38 |
| Support Level | $228.69 | $101.76 |
| Resistance Level | $234.30 | $109.80 |
| Average True Range (ATR) | 5.76 | 2.04 |
| MACD | 0.89 | 1.24 |
| Stochastic Oscillator | 83.07 | 92.31 |
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It intends to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.